Meta-analyses of secondary prevention studies, despite some heterogeneity, demonstrated that elevated Lp(a) levels are an independent predictor of cardiac and cardiovascular events in patients with coronary artery disease (27, 28). This evidence concerns the gene LPA and coronary artery disorder.